ELV

SEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 1

Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,518

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001737620-26-000002 · wk-form4_1772661505.xml · derivative · entry 5

LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Info Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,152

Underlying: Common Stock · 20,152 shares

Expires 2036-03-02

F4 · derivative.exercise_date: The option represents a right to purchase a total of 20,152 shares, and is exercisable in two installments of 6,717 shares each and one installment of 6,718 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

SEC source: 0001737620-26-000002 · wk-form4_1772661505.xml · nonDerivative · entry 3

LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Info Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,371

F3 · shares: Represents restricted share units. Restrictions lapse as follows: 3,401 shares each on 3/2/2027 and 3/2/2028.

SEC source: 0001737620-26-000002 · wk-form4_1772661505.xml · nonDerivative · entry 2

LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Info Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,569

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,700 shares each on 3/2/2027 and 3/2/2028, and 1,701 on 3/2/2029.

SEC source: 0001737620-26-000002 · wk-form4_1772661505.xml · nonDerivative · entry 1

LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Info Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,468

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001887908-26-000002 · wk-form4_1772661487.xml · derivative · entry 5

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,870

Underlying: Common Stock · 15,870 shares

Expires 2036-03-02

F4 · derivative.exercise_date: The option represents a right to purchase a total of 15,870 shares, and is exercisable in three annual installments, each installment of 5,290 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

SEC source: 0001887908-26-000002 · wk-form4_1772661487.xml · nonDerivative · entry 3

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,454

F3 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

SEC source: 0001887908-26-000002 · wk-form4_1772661487.xml · nonDerivative · entry 2

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,922

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029.

SEC source: 0001887908-26-000002 · wk-form4_1772661487.xml · nonDerivative · entry 1

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,905

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001608538-26-000002 · wk-form4_1772661470.xml · nonDerivative · entry 2

Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,668

F2 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

SEC source: 0001608538-26-000002 · wk-form4_1772661470.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,803

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001748691-26-000002 · wk-form4_1772661447.xml · derivative · entry 5

Kaye Mark · CIK 0001748691 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,188

Underlying: Common Stock · 25,188 shares

Expires 2036-03-02

F4 · derivative.exercise_date: The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

SEC source: 0001748691-26-000002 · wk-form4_1772661447.xml · nonDerivative · entry 3

Kaye Mark · CIK 0001748691 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,390

F3 · shares: Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028.

SEC source: 0001748691-26-000002 · wk-form4_1772661447.xml · nonDerivative · entry 2

Kaye Mark · CIK 0001748691 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,188

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029.

SEC source: 0001748691-26-000002 · wk-form4_1772661447.xml · nonDerivative · entry 1

Kaye Mark · CIK 0001748691 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,811

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001287920-26-000002 · wk-form4_1772661402.xml · derivative · entry 6

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,818

Underlying: Common Stock · 63,818 shares

Expires 2036-03-02

F4 · derivative.exercise_date: The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

SEC source: 0001287920-26-000002 · wk-form4_1772661402.xml · nonDerivative · entry 3

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,987

F3 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

SEC source: 0001287920-26-000002 · wk-form4_1772661402.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,460

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029.

SEC source: 0001287920-26-000002 · wk-form4_1772661402.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,307

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001438226-26-000005 · wk-form4_1770154954.xml · nonDerivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218

F1 · shares: Phantom Stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0002084547-26-000003 · wk-form4_1770153318.xml · nonDerivative · entry 1

Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,032

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001748691-25-000007 · wk-form4_1759522630.xml · nonDerivative · entry 1

Kaye Mark · CIK 0001748691 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,082

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0002084548-25-000004 · wk-form4_1757103700.xml · nonDerivative · entry 1

Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,020

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0002084548-25-000002 · wk-form4_1757001225.xml · derivative · entry 2

Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,541

Underlying: Common Stock · 3,541 shares

Expires 2035-09-02

F2 · derivative.exercise_date: The option represents a right to purchase a total of 3,541 shares, and is exercisable in three annual installments, with two installments of 1,180 shares each and one installment of 1,181 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date.

SEC source: 0002084548-25-000002 · wk-form4_1757001225.xml · nonDerivative · entry 1

Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,172

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 310 shares each on 9/2/2026 and 9/2/2027, and 311 on 9/2/2028.

SEC source: 0002084547-25-000002 · wk-form4_1757001184.xml · derivative · entry 2

Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,690

Underlying: Common Stock · 3,690 shares

Expires 2035-09-02

F2 · derivative.exercise_date: The option represents a right to purchase a total of 3,690 shares, and is exercisable in three annual installments of 1,230 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date.

SEC source: 0002084547-25-000002 · wk-form4_1757001184.xml · nonDerivative · entry 1

Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,353

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 323 shares each on 9/2/2026 and 9/2/2027, and 324 shares on 9/2/2028.

SEC source: 0001587697-25-000007 · wk-form4_1755807634.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,502

F1 · price: This transaction was executed in multiple purchases at prices ranging from $312.06 to $312.19. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-25-000124 · wk-form4_1754425101.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 639

F1 · shares: Phantom Stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001287920-25-000005 · wk-form4_1752860565.xml · nonDerivative · entry 3

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,020

F3 · price: This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001287920-25-000005 · wk-form4_1752860565.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,970

F2 · price: This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001287920-25-000005 · wk-form4_1752860565.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,854

F1 · price: This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-25-000092 · wk-form4_1747426756.xml · nonDerivative · entry 1

STRABLE-SOETHOUT DEANNA D · CIK 0001278726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,646

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000091 · wk-form4_1747426726.xml · nonDerivative · entry 1

Schneider Ryan M. · CIK 0001420501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,600

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000090 · wk-form4_1747426696.xml · nonDerivative · entry 1

PERU RAMIRO G · CIK 0001192045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,345

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000089 · wk-form4_1747426667.xml · nonDerivative · entry 1

Neri Antonio F · CIK 0001648401 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,925

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000088 · wk-form4_1747426626.xml · nonDerivative · entry 1

Jallal Bahija · CIK 0001730038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,788

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000087 · wk-form4_1747426585.xml · nonDerivative · entry 1

HAY LEWIS III · CIK 0001182705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,507

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000086 · wk-form4_1747426546.xml · nonDerivative · entry 1

Dixon Robert L JR · CIK 0001524849 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,322

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000085 · wk-form4_1747426507.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,302

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000084 · wk-form4_1747426452.xml · nonDerivative · entry 1

CLARK R KERRY · CIK 0001180776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,640

F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-25-000060 · wk-form4_1745612235.xml · nonDerivative · entry 1

Kaye Mark · CIK 0001748691 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,977

F1 · price: This transaction was executed in multiple trades, each at the same price of $424.82.

SEC source: 0001156039-25-000038 · wk-form4_1741724430.xml · nonDerivative · entry 1

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,847

F1 · price: This transaction was executed in multiple trades, each at the same price of $415.13.

SEC source: 0001156039-25-000035 · wk-form4_1741215166.xml · nonDerivative · entry 4

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,116

F4 · price: This transaction was executed in multiple trades, each at the same price of $396.30.

F5 · balance_after: Balance includes 22.89 shares acquired on December 20, 2024 through a dividend reinvestment plan.

SEC source: 0001156039-25-000035 · wk-form4_1741215166.xml · derivative · entry 5

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,828

Underlying: Common Stock · 10,828 shares

Expires 2035-03-03

F6 · derivative.exercise_date: The option represents a right to purchase a total of 10,828 shares, and is exercisable in three annual installments, with two installments of 3,609 shares each and one installment of 3,610 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.

SEC source: 0001156039-25-000035 · wk-form4_1741215166.xml · nonDerivative · entry 3

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,620

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/3/2025.

SEC source: 0001156039-25-000035 · wk-form4_1741215166.xml · nonDerivative · entry 2

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,934

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 948 shares each on 3/3/2026 and 3/3/2027, and 949 shares on 3/3/2028.

SEC source: 0001156039-25-000035 · wk-form4_1741215166.xml · nonDerivative · entry 1

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,089

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-25-000032 · wk-form4_1741211844.xml · derivative · entry 4

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,081

Underlying: Common Stock · 1,081 shares

Expires 2035-03-03

F5 · derivative.exercise_date: The option represents a right to purchase a total of 1,081 shares, and is exercisable in three annual installments, with two installments of 360 shares each and one installment of 361 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.

SEC source: 0001156039-25-000032 · wk-form4_1741211844.xml · nonDerivative · entry 3

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,290

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/3/2025.

F4 · balance_after: Balance includes 4.18 shares acquired on March 22, 2024, 3.99 shares acquired on June 25, 2024, 4.07 shares acquired on September 25, 2024 and 5.95 shares acquired on December 20, 2024 through a dividend reinvestment plan.